Rationale and design of a randomized phase II trial of the first-line treatment of extensive stage small cell lung cancer with the combination of Envafolimab, etoposide, and carboplatin with or without trilaciclib (SMA-SCLC-005 study) - Amsterdam 2025

Small cell lung cancer and rare tumours

Chair(s): Katerina Bakiri, Jacques Cadranel

Session type: Poster session

Rationale and design of a randomized phase II trial of the first-line treatment of extensive stage small cell lung cancer with the combination of Envafolimab, etoposide, and carboplatin with or without trilaciclib (SMA-SCLC-005 study)

Yan Zhou

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

The Role of Endosonography in the Diagnosis of Small Cell Neuroendocrine Lung Cancer

Carmine Salerni

Poster

Abstract

Real-world (rw) outcomes with first-line chemoimmunotherapy in extensive-stage small-cell lung cancer (ES SCLC)

Emmanouil Panagiotou

Poster

Abstract

Characteristics of lung cancer patients exposed to environmental asbestos in rural areas.

Selma Metintas

Abstract

Clinical research of combined first-line treatment with everolimus and EP chemotherapy in advanced pulmonary large cell neuroendocrine carcinoma

Shuanglong Xiong

Poster

Abstract

The impact of radiotherapy on the efficacy of chemotherapy with or without immunotherapy in small cell lung cancer

Sheng-fu Chen

Poster

Abstract

Profiling risk of recurrence and second primary after curative surgery for lung cancer

Farhan Huq

Poster

Abstract

Insights into adenoid cystic carcinoma of the lower airway (ACCLA): a 10-year experience

Carolina Mariana Da Silva Alves

Poster

Abstract

Yan Zhou

Poster

Abstract

Primary pulmonary adenoid cystic carcinoma: surgical approch

Mahdi Abdennadher

Poster

Abstract

Exploring the rare occurrence of small cell lung carcinoma following squamous cell carcinoma of the lung: A case series and a call for enhanced diagnostic evaluation

Prajna Gopalakrishna

Abstract

Coexistence of Neuroendocrine Tumorlets and Lung Adenocarcinoma: A Subtle Observer or an Underestimated Threat?

Susmita Debbarma

Poster

Abstract

A RETROSPECTIVE REAL-WORLD EVALUATION OF ATEZOLIZUMAB IN PATIENT WITH SMALL CELL LUNG CANCER (SCLC): A MONOCENTRIC STUDY

Raffaella Pagliaro

Poster

Abstract

Prognostic significance of procalcitonin levels in Small Cell Lung Cancer patients

Paschalina Tsopa

Poster

Abstract

Late Breaking Abstract - Next-generation-sequencing of extracellular vesicles from bronchial washing fluid in advanced lung cancer.

Teresa Calari

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}